Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Antibiotics for lower Respiratory Tract Infection in Children presenting in Primary Care (ARTIC PC): a randomised placebo controlled trial

Little, Paul, Francis, Nick A., Stuart, Beth, O'Reilly, Gilly, Thompson, Natalie, Becque, Taeko, Hay, Alastair D, Want, Kay, Sharland, Michael, Harnden, Anthony, Yao, Guiqing, Raftery, James, Zhu, Shihua, Little, Joseph, Hookham, Charlotte, Rowley, Kate, Euden, Joanne ORCID:, Harman, Kim, Coenen, Samuel, Read, Robert C., Woods, Catherine, Butler, C., Faust, Saul N., Leyon, Geralding, Wan, Mandy, Hood, Kerenza ORCID:, Whitehurst, Jane, Richards-Hall, Samantha, Smith, Peter, Thomas, Michael, Moore, Michael and Verheij, Theo 2021. Antibiotics for lower Respiratory Tract Infection in Children presenting in Primary Care (ARTIC PC): a randomised placebo controlled trial. The Lancet 398 , pp. 1417-1426. 10.1016/S0140-6736(21)01431-8

[thumbnail of PIIS0140673621014318.pdf] PDF - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (582kB)


Background Antibiotic resistance is a global public health threat. Antibiotics are very commonly prescribed for children presenting with uncomplicated lower respiratory tract infections (LRTIs), but there is little evidence from randomised controlled trials of the effectiveness of antibiotics, both overall or among key clinical subgroups. In ARTIC PC, we assessed whether amoxicillin reduces the duration of moderately bad symptoms in children presenting with uncomplicated (non-pneumonic) LRTI in primary care, overall and in key clinical subgroups. Methods ARTIC PC was a double-blind, randomised, placebo-controlled trial done at 56 general practices in England. Eligible children were those aged 6 months to 12 years presenting in primary care with acute uncomplicated LRTI judged to be infective in origin, where pneumonia was not suspected clinically, with symptoms for less than 21 days. Patients were randomly assigned in a 1:1 ratio to receive amoxicillin 50 mg/kg per day or placebo oral suspension, in three divided doses orally for 7 days. Patients and investigators were masked to treatment assignment. The primary outcome was the duration of symptoms rated moderately bad or worse (measured using a validated diary) for up to 28 days or until symptoms resolved. The primary outcome and safety were assessed in the intention-to-treat population. The trial is registered with the ISRCTN Registry (ISRCTN79914298). Findings Between Nov 9, 2016, and March 17, 2020, 432 children (not including six who withdrew permission for use of their data after randomisation) were randomly assigned to the antibiotics group (n=221) or the placebo group (n=211). Complete data for symptom duration were available for 317 (73%) patients; missing data were imputed for the primary analysis. Median durations of moderately bad or worse symptoms were similar between the groups (5 days [IQR 4–11] in the antibiotics group vs 6 days [4–15] in the placebo group; hazard ratio [HR] 1·13 [95% CI 0·90–1·42]). No differences were seen for the primary outcome between the treatment groups in the five prespecified clinical subgroups (patients with chest signs, fever, physician rating of unwell, sputum or chest rattle, and short of breath). Estimates from complete-case analysis and a per-protocol analysis were similar to the imputed data analysis. Interpretation Amoxicillin for uncomplicated chest infections in children is unlikely to be clinically effective either overall or for key subgroups in whom antibiotics are commonly prescribed. Unless pneumonia is suspected, clinicians should provide safety-netting advice but not prescribe antibiotics for most children presenting with chest infections.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Centre for Trials Research (CNTRR)
Additional Information: This is an Open Access article under the CC BY-NC-ND 4.0 license.
Publisher: Elsevier
ISSN: 0140-6736
Date of First Compliant Deposit: 23 September 2021
Date of Acceptance: 21 June 2021
Last Modified: 07 May 2023 08:42

Actions (repository staff only)

Edit Item Edit Item


Downloads per month over past year

View more statistics